Morten Karsdal

Company: Nordic Bioscience

Job title: Chief Executive Officer

Seminars:

Is a Treatable Endotype for HFpEF the Missing Link for Successful Clinical Trials? 9:30 am

Understanding ECM signaling can give cues to better treatment strategies Endotrophin, a Type VI collagen hormone, is highly prognostic for outcome in HFpEF patients The endotrophin biomarker could be the key to identifying patients with better response to treatmentRead more

day: Day One